Get startedLog in
    Picture of Aptose Biosciences logo

    APTOF — Aptose Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Aptose Biosciences - Hm43239 Demonstrates Durable Clinical Benefit In Acute Myeloid Leukemia

    Picture of Aptose Biosciences logoAptose Biosciences
    13/12/2021 22:37
    Dec 13 (Reuters) - Aptose Biosciences Inc  APS.TO :
    * APTOSE BIOSCIENCES - HM43239 DEMONSTRATES DURABLE CLINICAL
BENEFIT IN ACUTE MYELOID LEUKEMIA
    * APTOSE BIOSCIENCES INC - HM43239 DATA FEATURED IN ORAL
PRESENTATION AT AMERICAN SOCIETY OF HEMATOLOGYANNUAL MEETING

Source text for Eikon:  ID:nGNX4vPpwL 
Further company coverage:  APS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Aptose Biosciences

    See all news